{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:31:00Z","timestamp":1794335460987,"version":"4.9.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator. It is expensive, frequently used, and not without risk. There is limited evidence supporting a standard approach to initiation and weaning. Our objective was to optimize the use of iNO in the cardiac ICU (CICU), PICU, and neonatal ICU (NICU) by establishing a standard approach to iNO utilization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>A quality improvement study using a prospective cohort design with historical controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Four hundred seven-bed free standing quaternary care academic children\u2019s hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>All patients on iNO in the CICU, PICU, and NICU from January 1, 2017 to December 31, 2022.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>Unit-specific standard approaches to iNO initiation and weaning.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Sixteen thousand eighty-seven patients were admitted to the CICU, PICU, and NICU with 9343 in the pre-iNO pathway era (January 1, 2017 to June 30, 2020) and 6744 in the postpathway era (July 1, 2020 to December 31, 2022). We found a decrease in the percentage of CICU patients initiated on iNO from 17.8% to 11.8% after implementation of the iNO utilization pathway. We did not observe a change in iNO utilization between the pre- and post-iNO pathway eras in either the PICU or NICU. Based on these data, we estimate 564 total days of iNO (\u201324%) were saved over 24 months in association with the standard pathway in the CICU, with associated cost savings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Implementation of a standard pathway for iNO use was associated with a statistically discernible reduction in total iNO usage in the CICU, but no change in iNO use in the NICU and PICU. These differential results likely occurred because of multiple contextual factors in each care setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003544","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T14:03:33Z","timestamp":1716559413000},"page":"e347-e357","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Changes in Inhaled Nitric Oxide Use Across ICUs After Implementation of a Standard Pathway"],"prefix":"10.1097","volume":"25","author":[{"given":"Monique","family":"Radman","sequence":"first","affiliation":[{"name":"Division of Cardiac Critical Care Medicine, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McGuire","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sharek","sequence":"additional","affiliation":[{"name":"Center for Quality and Patient Safety, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harris","family":"Baden","sequence":"additional","affiliation":[{"name":"Division of Cardiac Critical Care Medicine, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Koth","sequence":"additional","affiliation":[{"name":"Division of Cardiac Critical Care Medicine, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"DiGeronimo","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Migita","sequence":"additional","affiliation":[{"name":"Center for Quality and Patient Safety, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight","family":"Barry","sequence":"additional","affiliation":[{"name":"Clinical Analytics, Department of Pediatrics, Seattle Children\u2019s Hospital, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Johnson","sequence":"additional","affiliation":[{"name":"Clinical Analytics, Department of Pediatrics, Seattle Children\u2019s Hospital, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Rutman","sequence":"additional","affiliation":[{"name":"Center for Quality and Patient Safety, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi","family":"Vora","sequence":"additional","affiliation":[{"name":"Center for Quality and Patient Safety, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fped.2020.00441","article-title":"Childhood obesity, endothelial cell activation, and critical illness.","volume":"8","author":"Radman","year":"2020","journal-title":"Front Pediatr"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.33549\/physiolres.933673","article-title":"Physiology of nitric oxide in the respiratory system.","volume":"66","author":"Antosova","year":"2017","journal-title":"Physiol Res"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201304-0686PP","article-title":"Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension.","volume":"188","author":"Klinger","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1542\/peds.101.3.325","article-title":"Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study.","volume":"101","author":"Davidson","year":"1998","journal-title":"Pediatrics"},{"key":"R5-20250502","first-page":"CD000399","article-title":"Nitric oxide for respiratory failure in infants born at or near term.","volume":"2017","author":"Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1053\/j.jvca.2018.02.003","article-title":"Nitric oxide in cardiac surgery: A meta-analysis of randomized controlled trials.","volume":"32","author":"Sardo","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/PCC.0000000000003344","article-title":"Improving outcomes for infants after cardiopulmonary bypass surgery for congenital heart disease: A commentary on recent randomized controlled trials.","volume":"24","author":"Schlapbach","year":"2023","journal-title":"Pediatr Crit Care Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1097\/PCC.0000000000003162","article-title":"Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome: From the second pediatric acute lung injury consensus conference.","volume":"24","author":"Rowan","year":"2023","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20250502","first-page":"CD005055","article-title":"Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease.","volume":"2014","author":"Bizzarro","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/anae.13628","article-title":"The effect of inhaled nitric oxide in acute respiratory distress syndrome in children and adults: A Cochrane systematic review with trial sequential analysis.","volume":"72","author":"Karam","year":"2017","journal-title":"Anaesthesia"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"e20161472","DOI":"10.1542\/peds.2016-1472","article-title":"Neonatal jaundice: Improved quality and cost savings after implementation of a standard pathway.","volume":"141","author":"Romero","year":"2018","journal-title":"Pediatrics"},{"key":"R12-20250502","article-title":"Asthma pathway.","author":"Ken","year":"2024"},{"key":"R13-20250502","article-title":"Bronchiolitis pathway.","author":"Chang","year":"2020"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1542\/peds.2013-3764","article-title":"Improving care for pediatric diabetic ketoacidosis.","volume":"134","author":"Koves","year":"2014","journal-title":"Pediatrics"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1542\/hpeds.2017-0099","article-title":"Outcomes of a clinical pathway to standardize use of maintenance intravenous fluids.","volume":"7","author":"Rooholamini","year":"2017","journal-title":"Hosp Pediatr"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"e20151202","DOI":"10.1542\/peds.2015-1202","article-title":"Standardized clinical pathways for hospitalized children and outcomes.","volume":"137","author":"Lion","year":"2016","journal-title":"Pediatrics"},{"key":"R17-20250502","first-page":"677","article-title":"Letters, numbers, symbols and words: How to communicate grades of evidence and recommendations.","volume":"169","author":"Sch\u00fcnemann","year":"2003","journal-title":"CMAJ"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1214\/14-AOAS788","article-title":"Inferring causal impact using Bayesian structural time-series models.","volume":"9","author":"Brodersen","year":"2015","journal-title":"Ann Appl Stat"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): Revised publication guidelines from a detailed consensus process.","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/bmj.325.7359.336","article-title":"Cost of nitric oxide is exorbitant.","volume":"325","author":"Pierce","year":"2002","journal-title":"BMJ"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4187\/respcare.03308","article-title":"Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use.","volume":"60","author":"Tzanetos","year":"2015","journal-title":"Respir Care"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1097\/00003246-200008000-00048","article-title":"Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease.","volume":"28","author":"Morris","year":"2000","journal-title":"Crit Care Med"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(00)02869-5","article-title":"Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: A randomised double-blind study.","volume":"356","author":"Miller","year":"2000","journal-title":"Lancet"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0003-4975(00)01312-6","article-title":"Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease.","volume":"69","author":"Day","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1213\/00000539-199807000-00011","article-title":"The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease.","volume":"87","author":"Russell","year":"1998","journal-title":"Anesth Analg"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.clp.2021.05.009","article-title":"Pathophysiology and management of persistent pulmonary hypertension of the newborn.","volume":"48","author":"Singh","year":"2021","journal-title":"Clin Perinatol"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000542-200207000-00030","article-title":"The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist.","volume":"97","author":"Laffey","year":"2002","journal-title":"Anesthesiology"},{"key":"R29-20250502","first-page":"566","article-title":"Characterization of inhaled nitric oxide use for cardiac indications in pediatric patients.","volume":"29","author":"Yates","year":"2022","journal-title":"Chin Pediatr Emerg Med"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/PCC.0000000000002928","article-title":"Inhaled nitric oxide in pediatric cardiac intensive care\u2014the first 30 years.","volume":"23","author":"Macrae","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/QMH.0000000000000167","article-title":"A stewardship program to optimize the use of inhaled nitric oxide in pediatric critical care.","volume":"27","author":"Genova","year":"2018","journal-title":"Qual Manag Heal Care"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1542\/peds.112.6.1351","article-title":"Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States.","volume":"112","author":"Angus","year":"2003","journal-title":"Pediatrics"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/PCC.0000000000001535","article-title":"Variability in antibiotic use across PICUs.","volume":"19","author":"Brogan","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpeds.2005.05.008","article-title":"Regional variation in ICU care for pediatric patients with asthma.","volume":"147","author":"Bratton","year":"2005","journal-title":"J Pediatr"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:39:01Z","timestamp":1746207541000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003544","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,24]]}}}